JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SI
4201
DELISTED
Silvergate Capital Corporation
SI
| $158K | ﹤0.01% |
11,283
+5,833
| +107% | +$78.7K |
2019 Q4
2 quarters
|
|
|
WMC
4202
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $158K | ﹤0.01% |
5,765
-12,266
| -68% | -$314K |
2015 Q2
20 quarters
|
|
4203
Carriage Services
CSV
$513M
| $157K | ﹤0.01% |
8,670
-24,217
| -74% | -$408K |
2015 Q4
18 quarters
|
|
4204
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.36B
| $157K | ﹤0.01% |
2,890
-1,600
| -36% | -$78.8K |
2013 Q2
28 quarters
|
|
|
PS
4205
PUT
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $157K | ﹤0.01% |
+8,700
| New | +$147K |
2020 Q2
0 quarters
|
|
|
AXDX
4206
DELISTED
Accelerate Diagnostics
AXDX
| $156K | ﹤0.01% |
1,026
+131
| +15% | +$12.9K |
2017 Q4
10 quarters
|
|
4207
RGC Resources
RGCO
$225M
| $156K | ﹤0.01% |
6,436
-6,271
| -49% | -$159K |
2017 Q4
10 quarters
|
|
4208
Schwab US Broad Market ETF
SCHB
$45.2B
| $156K | ﹤0.01% |
12,744
+258
| +2% | +$2.97K |
2017 Q1
13 quarters
|
|
4209
Transcat
TRNS
$848M
| $156K | ﹤0.01% |
6,044
-7,015
| -54% | -$183K |
2019 Q1
5 quarters
|
|
4210
Westwood Holdings Group
WHG
$182M
| $156K | ﹤0.01% |
9,973
-10,783
| -52% | -$205K |
2017 Q4
10 quarters
|
|
4211
X4 Pharmaceuticals
XFOR
$288M
| $155K | ﹤0.01% |
557
+430
| +339% | +$118K |
2017 Q4
10 quarters
|
|
|
MOR
4212
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $155K | ﹤0.01% |
4,886
+3,495
| +251% | +$102K |
2018 Q2
8 quarters
|
|
|
ALTG.WS
4213
DELISTED
Alta Equipment Group Warrants
ALTG.WS
| – | – |
0
| – | – |
2020 Q2
0 quarters
|
|
|
DRRX
4214
DELISTED
DURECT Corp
DRRX
| $154K | ﹤0.01% |
+6,655
| New | +$146K |
2020 Q2
0 quarters
|
|
4215
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
$6.98B
| $154K | ﹤0.01% |
5,565
+5,555
| +55,550% | +$146K |
2018 Q2
8 quarters
|
|
|
NAGE
4216
Niagen Bioscience
NAGE
$212M
| $154K | ﹤0.01% |
33,527
+20,393
| +155% | +$91.3K |
2018 Q2
8 quarters
|
|
|
ITI
4217
DELISTED
Iteris, Inc.
ITI
| $154K | ﹤0.01% |
32,624
-42,422
| -57% | -$177K |
2017 Q4
10 quarters
|
|
4218
Fortress Biotech
FBIO
$69.7M
| $153K | ﹤0.01% |
3,810
+1,977
| +108% | +$73.4K |
2019 Q3
3 quarters
|
|
|
NYMX
4219
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $153K | ﹤0.01% |
+42,984
| New | +$136K |
2020 Q2
0 quarters
|
|
|
DVAX
4220
CALL
DELISTED
Dynavax Technologies
DVAX
| $152K | ﹤0.01% |
+17,100
| New | +$86.4K |
2020 Q2
0 quarters
|
|
4221
PCB Bancorp
PCB
$394M
| $152K | ﹤0.01% |
14,797
-9,779
| -40% | -$88.6K |
2018 Q3
7 quarters
|
|
4222
Pure Cycle
PCYO
$262M
| $152K | ﹤0.01% |
16,599
+3,658
| +28% | +$35.8K |
2017 Q4
10 quarters
|
|
|
CAMP
4223
DELISTED
CalAmp Corp.
CAMP
| $152K | ﹤0.01% |
822
-2,121
| -72% | -$328K |
2015 Q2
20 quarters
|
|
|
BCEL
4224
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $152K | ﹤0.01% |
7,176
+1,618
| +29% | +$28.6K |
2019 Q3
3 quarters
|
|
|
BVH
4225
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $152K | ﹤0.01% |
11,973
+7,754
| +184% | +$75K |
2018 Q2
8 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.